Document is current
Any future updates will be listed below
-
Authors
Bremard, Lisa
Wallart, Lisa
Lahaye, Emilie
Ben Mlouka, Mohamed Amine
Seitz, Jochen
Herpertz-Dahlmann, Beate
Fetissov, Sergueï O.
-
Funding
Funding for this research was provided by:
EU ERANET Neuron Program (01EW1906A-01EW1906B, 01EW1906A-01EW1906B, 01EW1906A-01EW1906B)
- License Information
-
More Information
Article History
Received: 1 July 2025
Accepted: 21 October 2025
First Online: 26 November 2025
Competing interests
: Authors declare no conflict of interest in relation to this study. SOF was a co-founder of TargEDys SA and is an inventor on the patent protecting the use of anorexigenic properties of ClpB (WO2015082633A1). The patent is licensed to BIOCODEX, France, which manufactures and commercializes ClpB-producing Hafnia alvei probiotic for the control of body weight.
